The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...

全面介紹

Na minha lista:
書目詳細資料
發表在:HPB (Oxford)
Main Authors: Sarpel, Umut, Spivack, John H., Berger, Yaniv, Heskel, Marina, Aycart, Samantha N., Sweeney, Robert, Edwards, Martin P., Labow, Daniel M., Kim, Edward
格式: Artigo
語言:Inglês
出版: Elsevier 2016
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/
https://ncbi.nlm.nih.gov/pubmed/27154804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍